Palvella Therapeutics (PVLA) Return on Sales (2014 - 2024)
Palvella Therapeutics (PVLA) reported Return on Sales of 0.0% for Q3 2024, up 1.0% year-over-year from 0.0% in Q4 2023, and up 95.16% quarter-over-quarter from 0.0% in Q2 2024.
Palvella Therapeutics (PVLA) Return on Sales (2014 - 2024) Analysis & Trends
Palvella Therapeutics (PVLA) has 11 years of Return on Sales data on file, last reported at 0.0% in Q3 2024.
- Return on Sales for Q3 2024 came in at 0.0%, up 1.0% year-over-year; the trailing twelve-month figure through Sep 2024 was 0.0% (up 1.0% YoY), and the FY2021 annual result was 0.02%, changed 0.0% from the prior year.
- Return on Sales advanced to 0.0% in Q3 2024 per PVLA's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q2 2023 and troughed at 0.48% in Q1 2024.
- A 5-year average of 0.08% and a median of 0.02% in 2021 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2023 and 2024: Return on Sales soared 46 bps in 2023, then tumbled 40 bps in 2024.
- A 5-year view of Return on Sales shows it stood at 0.07% in 2020, then soared by 66 bps to 0.02% in 2021, then sank by 1986 bps to 0.46% in 2022, then jumped by 98 bps to 0.01% in 2023, then surged by 99 bps to 0.0% in 2024.
- Business Quant data shows PVLA's Return on Sales at 0.0% in Q3 2024, 0.0% in Q2 2024, and 0.48% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Palvella Therapeutics | 1.37 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.48% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.08% |
| Sep 30, 2022 | -0.46% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.07% |
| Jun 30, 2021 | -0.07% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -0.07% |
| Sep 30, 2020 | -0.04% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -0.02% |